#AACR 2020

Recent studies suggest chemotherapy and immunotherapy are not linked to more severe COVID-19.

However, they are also more likely to miss medical appointments—especially women who don’t have child care.

Studies suggest BTK inhibitors and hormone therapy might lessen disease severity and speed recovery.

Here are a few highlights related to melanoma from the first-ever Virtual AACR Annual Meeting and Virtual ASCO Annual Meeting.

Combining a custom cancer vaccine and a checkpoint inhibitor generated tumor-specific immune responses in a majority of patients.

Sociodemographic factors may play a role in whether people receive immunotherapy.

The American Association for Cancer Research Annual Meeting goes virtual.

Cholesterol-lowering medications were associated with at least a 40% reduction in mortality.

These cancers include those that are rare among adults under 40, such as breast, colon, pancreas, kidney, prostate and ovarian cancer.

A recent study found that blood testing could help with early detection of numerous malignancies.

An early study in mice had suggested the on-again, off-again dosing strategy would help shrink tumors.

A study of melanoma patients found that treatment every six weeks is comparable to every three weeks.

Cancer type, stage and treatment appear to affect the likelihood of poor outcomes.

Those with blood cancers or lung cancer fared poorly in the first U.S. study of the new coronavirus n people with cancer.

Cancer-fighting T cells led to complete or partial tumor remission in at least 25% of lung cancer patients.